Sevion Therapeutics, Inc. (SVON)

Oncology Corporate Profile

Stock Performance

0.2100
-0.0100

3 Month Stock History Chart

HQ Location

4045 Sorrento Valley Blvd
San Diego, CA 92121

Company Description

Sevion is a biopharmaceutical company which discovers, develops and acquires innovative product candidates for the treatment of cancer and immunological diseases. The Company is advancing a pipeline of proprietary and partnered product candidates that leverages its unique antibody technology platforms. The Company's antibody pipeline is being developed from technology that allows for the discovery of innovative biologic therapies to previously inaccessible targets, such as multispanning membrane proteins and ion channels that play an important role in multiple diseases. The Company also developed the first protein nanocage system allowing delivery of nucleic acids and other payloads to target cells.

Website: http://www.seviontherapeutics.com/

This company does not have any commercial products
  • Brand
  • Generic
  • Investigational
Brand / Product Class Area of Study Phase Partnership
SVN-002antibody drug conjugate (ADC)Various cancer typesPreclinical

View additional information on product candidates here »

Source: http://www.seviontherapeutics.com/

Recent News Headlines

8/21/2017 06:22 am

8/1/2017 06:19 pm

Harlan Waksal, M.D. resigns as Chairman of the Board of Sevion Therapeutics

3/11/2016 03:00 am

[Business Wire] - Sevion Therapeutics, Inc. , a biopharmaceutical company which discovers, develops and acquires next-generation biologics for the treatment of cancer and immunological diseases, today announced that Dr.

Sevion Therapeutics Reports First Quarter 2016 Financial Results

11/17/2015 10:03 pm

[at noodls] - Sevion Therapeutics, Inc. ('Sevion' or the 'Company')(OTCQB:SVON), a biopharmaceutical company which discovers, develops and acquires next-generation biologics for the treatment of cancer and immunological ...

Sevion Therapeutics Reports First Quarter 2016 Financial Results

11/17/2015 10:00 pm

[Business Wire] - Sevion Therapeutics, Inc. , a biopharmaceutical company which discovers, develops and acquires next-generation biologics for the treatment of cancer and immunological diseases, today reported financial results for the fiscal quarter ended September 30, 2015 .

Sevion Therapeutics Presents Cow Antibody Platform at Protein Discovery Summit

10/21/2015 10:01 am

[at noodls] - Sevion Therapeutics, Inc. ('Sevion' or the 'Company') (OTCBB:SVON), a biopharmaceutical company which discovers, develops and acquires next-generation biologics for the treatment of cancer and immunological ...

Sevion Therapeutics Presents Cow Antibody Platform at Protein Discovery Summit

10/21/2015 10:00 am

[Business Wire] - Sevion Therapeutics, Inc. , a biopharmaceutical company which discovers, develops and acquires next-generation biologics for the treatment of cancer and immunological diseases, today announced that Dr.

Sevion Therapeutics Reports Fiscal Year 2015 Financial Results

10/14/2015 10:00 pm

[at noodls] - Sevion Therapeutics, Inc. ('Sevion' or the 'Company') (OTCQB:SVON), a biopharmaceutical company which discovers, develops and acquires next-generation biologics for the treatment of cancer and immunological ...

Sevion Therapeutics Reports Fiscal Year 2015 Financial Results

10/14/2015 09:04 pm

[Business Wire] - Sevion Therapeutics, Inc. , a biopharmaceutical company which discovers, develops and acquires next-generation biologics for the treatment of cancer and immunological diseases, today reported financial results for the fiscal year ended June 30, 2015 and also provided an overview of corporate accomplishments and plans.

Sevion Therapeutics Presents Antibody Discovery Platform at International Conference

9/22/2015 10:01 am

[at noodls] - September 22, 2015 Sevion Therapeutics, Inc. ('Sevion' or the 'Company') (OTCBB:SVON), a biopharmaceutical company which discovers, develops, and acquires next-generation biologics for the treatment of ...

Sevion Therapeutics Presents Antibody Discovery Platform at International Conference

9/22/2015 10:00 am

[Business Wire] - Sevion Therapeutics, Inc. , a biopharmaceutical company which discovers, develops, and acquires next-generation biologics for the treatment of cancer and immunological diseases, today announced that Dr.